This study uses data from a Drug Enforcement Administration list of Drug Addiction Treatment Act (DATA)-waivered clinicians to examine trends in DATA-waivered clinicians’ active participation in prescribing buprenorphine overall and by patient limits between January 2017 and May 2021.
Source: JAMA Online First